NMR Experiment |
---|
Experiment | Type | Sample Contents | Solvent | Ionic Strength | pH | Pressure | Temperature (K) | Spectrometer |
---|
14 | 2D 1H-15N HSQC | 0.4 mM [U-100% 13C; U-100% 15N] CDHR3 extracellular domain EC1, 50 mM HEPES, 300 mM potassium chloride, 10 mM calcium chloride, 0.05 % w/v sodium azide, 10 % v/v [U-100% 2H] D2O | 90% H2O/10% D2O | 380 mM | 7.0 | 1 atm | 293 | Bruker AVANCE III 600 |
1 | 3D HNCACB | 0.4 mM [U-100% 13C; U-100% 15N] CDHR3 extracellular domain EC1, 50 mM HEPES, 300 mM potassium chloride, 10 mM calcium chloride, 0.05 % w/v sodium azide, 10 % v/v [U-100% 2H] D2O | 90% H2O/10% D2O | 380 mM | 7.0 | 1 atm | 293 | Bruker AVANCE III 600 |
2 | 3D CBCA(CO)NH | 0.4 mM [U-100% 13C; U-100% 15N] CDHR3 extracellular domain EC1, 50 mM HEPES, 300 mM potassium chloride, 10 mM calcium chloride, 0.05 % w/v sodium azide, 10 % v/v [U-100% 2H] D2O | 90% H2O/10% D2O | 380 mM | 7.0 | 1 atm | 293 | Bruker AVANCE III 600 |
3 | 3D HNCA | 0.4 mM [U-100% 13C; U-100% 15N] CDHR3 extracellular domain EC1, 50 mM HEPES, 300 mM potassium chloride, 10 mM calcium chloride, 0.05 % w/v sodium azide, 10 % v/v [U-100% 2H] D2O | 90% H2O/10% D2O | 380 mM | 7.0 | 1 atm | 293 | Bruker AVANCE III 600 |
4 | 3D HN(CO)CA | 0.4 mM [U-100% 13C; U-100% 15N] CDHR3 extracellular domain EC1, 50 mM HEPES, 300 mM potassium chloride, 10 mM calcium chloride, 0.05 % w/v sodium azide, 10 % v/v [U-100% 2H] D2O | 90% H2O/10% D2O | 380 mM | 7.0 | 1 atm | 293 | Bruker AVANCE III 600 |
5 | 3D HN(CA)CO | 0.4 mM [U-100% 13C; U-100% 15N] CDHR3 extracellular domain EC1, 50 mM HEPES, 300 mM potassium chloride, 10 mM calcium chloride, 0.05 % w/v sodium azide, 10 % v/v [U-100% 2H] D2O | 90% H2O/10% D2O | 380 mM | 7.0 | 1 atm | 293 | Varian VNMR 600 |
6 | 3D HNCO | 0.4 mM [U-100% 13C; U-100% 15N] CDHR3 extracellular domain EC1, 50 mM HEPES, 300 mM potassium chloride, 10 mM calcium chloride, 0.05 % w/v sodium azide, 10 % v/v [U-100% 2H] D2O | 90% H2O/10% D2O | 380 mM | 7.0 | 1 atm | 293 | Varian VNMR 600 |
7 | 3D HBHA(CO)NH | 0.4 mM [U-100% 13C; U-100% 15N] CDHR3 extracellular domain EC1, 50 mM HEPES, 300 mM potassium chloride, 10 mM calcium chloride, 0.05 % w/v sodium azide, 10 % v/v [U-100% 2H] D2O | 90% H2O/10% D2O | 380 mM | 7.0 | 1 atm | 293 | Varian VNMR 600 |
8 | 3D HCCH-TOCSY | 0.4 mM [U-100% 13C; U-100% 15N] CDHR3 extracellular domain EC1, 50 mM HEPES, 300 mM potassium chloride, 10 mM calcium chloride, 0.05 % w/v sodium azide, 10 % v/v [U-100% 2H] D2O | 90% H2O/10% D2O | 380 mM | 7.0 | 1 atm | 293 | Varian VNMR 600 |
9 | 3D HCCH-TOCSY | 0.4 mM [U-100% 13C; U-100% 15N] CDHR3 extracellular domain EC1, 50 mM HEPES, 300 mM potassium chloride, 10 mM calcium chloride, 0.05 % w/v sodium azide, 10 % v/v [U-100% 2H] D2O | 90% H2O/10% D2O | 380 mM | 7.0 | 1 atm | 293 | Varian VNMR 800 |
10 | 3D HCCH-COSY | 0.4 mM [U-100% 13C; U-100% 15N] CDHR3 extracellular domain EC1, 50 mM HEPES, 300 mM potassium chloride, 10 mM calcium chloride, 0.05 % w/v sodium azide, 10 % v/v [U-100% 2H] D2O | 90% H2O/10% D2O | 380 mM | 7.0 | 1 atm | 293 | Varian VNMR 800 |
11 | 3D NOESY 1H-15N HSQC | 0.4 mM [U-100% 13C; U-100% 15N] CDHR3 extracellular domain EC1, 50 mM HEPES, 300 mM potassium chloride, 10 mM calcium chloride, 0.05 % w/v sodium azide, 10 % v/v [U-100% 2H] D2O | 90% H2O/10% D2O | 380 mM | 7.0 | 1 atm | 293 | Varian VNMR 600 |
12 | 3D NOESY 1H-13C HSQC aliphatic | 0.4 mM [U-100% 13C; U-100% 15N] CDHR3 extracellular domain EC1, 50 mM HEPES, 300 mM potassium chloride, 10 mM calcium chloride, 0.05 % w/v sodium azide, 10 % v/v [U-100% 2H] D2O | 90% H2O/10% D2O | 380 mM | 7.0 | 1 atm | 293 | Varian VNMR 600 |
13 | 2D 1H-13C HSQC aliphatic | 0.4 mM [U-100% 13C; U-100% 15N] CDHR3 extracellular domain EC1, 50 mM HEPES, 300 mM potassium chloride, 10 mM calcium chloride, 0.05 % w/v sodium azide, 10 % v/v [U-100% 2H] D2O | 90% H2O/10% D2O | 380 mM | 7.0 | 1 atm | 293 | Varian VNMR 800 |